Literature DB >> 15556806

Corticobasal degeneration.

Robert K Mahapatra1, Mark J Edwards, Jonathan M Schott, Kailash P Bhatia.   

Abstract

Corticobasal degeneration is a progressive neurodegenerative disease that typically presents with asymmetrical parkinsonism and cognitive dysfunction. Recent molecular advances have given some clues to the pathogenesis of the disease. Clinical diagnosis is complicated by both the variability of presentation of true corticobasal degeneration, for example as a dementing illness, and the syndromes that look like it but are caused by other neurodegenerative diseases. Although definitive diagnosis of corticobasal degeneration can only be made at post-mortem examination, recent advances in imaging can assist the clinician with diagnosis. Treatment options remain limited and mostly address symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15556806     DOI: 10.1016/S1474-4422(04)00936-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  23 in total

1.  Impaired information integration contributes to communication difficulty in corticobasal syndrome.

Authors:  Rachel G Gross; Sharon Ash; Corey T McMillan; Delani Gunawardena; Chivon Powers; David J Libon; Peachie Moore; Tsao-Wei Liang; Murray Grossman
Journal:  Cogn Behav Neurol       Date:  2010-03       Impact factor: 1.600

Review 2.  PET/CT in diagnosis of movement disorders.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

Review 3.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

4.  Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.

Authors:  Ian Diner; Chadwick M Hales; Isaac Bishof; Lake Rabenold; Duc M Duong; Hong Yi; Oskar Laur; Marla Gearing; Juan Troncoso; Madhav Thambisetty; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

5.  A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

Authors:  James Y Garbern; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee; Gerald Feldman; Joy W Norris; Michael J Friez; Charles E Schwartz; Roger Stevenson; Anders A F Sima
Journal:  Brain       Date:  2010-04-15       Impact factor: 13.501

6.  A progranulin mutation associated with cortico-basal syndrome in an Italian family expressing different phenotypes of fronto-temporal lobar degeneration.

Authors:  Cinzia Coppola; Giacomina Rossi; Anna Maria Barbarulo; Giuseppe Di Fede; Carolina Foglia; Elena Piccoli; Giuseppe Piscosquito; Dario Saracino; Fabrizio Tagliavini; Roberto Cotrufo
Journal:  Neurol Sci       Date:  2011-06-22       Impact factor: 3.307

Review 7.  Update on apraxia.

Authors:  Rachel Goldmann Gross; Murray Grossman
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

8.  Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum.

Authors:  Rafael R Lima; Joanilson Guimaraes-Silva; Jorge L Oliveira; Ana Maria R Costa; Renata D Souza-Rodrigues; Claudia D Dos Santos; Cristovam W Picanço-Diniz; Walace Gomes-Leal
Journal:  Inflammation       Date:  2007-09-25       Impact factor: 4.092

9.  Corticobasal degeneration.

Authors:  Stephen G Reich; Stephen E Grill
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

10.  A disease-specific metabolic brain network associated with corticobasal degeneration.

Authors:  Martin Niethammer; Chris C Tang; Andrew Feigin; Patricia J Allen; Lisette Heinen; Sabine Hellwig; Florian Amtage; Era Hanspal; Jean Paul Vonsattel; Kathleen L Poston; Philipp T Meyer; Klaus L Leenders; David Eidelberg
Journal:  Brain       Date:  2014-09-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.